A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety

Journal of Interventional Cardiac Electrophysiology

Volumn 43, Issue 1, 2015, Pages 65-75

  Qintar, Mohammed ^a,d,e   George, Jason J ^a,d,e   Panko, Melanie ^a,d,e   Bea, Scott ^a,d,e   Broer, Karen A ^a,d,e   St John, Julie ^a,d,e   Blissett, Kecia Ann ^a,d,e   Ching, Elizabeth ^a,d,e   Sears, Samuel F ^b,d,e   Pedersen, Susanne S ^c,d,e   Pozuelo, Leopoldo ^a,d,e   Chung, Mina K ^a,d,e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e TILBURG UNIVERSITY   (Netherlands)

Author keywords

Anxiety; Cognitive behavioral therapy; Defibrillation; ICD; Shock

Indexed keywords

ADVERSE EFFECTS; COGNITIVE THERAPY; CONTROLLED STUDY; ETIOLOGY; FEMALE; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MENTAL STRESS; MIDDLE AGED; PILOT STUDY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; THERAPY; TREATMENT OUTCOME;

COGNITIVE THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84939990080     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-015-9990-7     Document Type: Article

References (34)

1. Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., et al. (2008). Prognostic importance of defibrillator shocks in patients with heart failure. New England Journal of Medicine, 359(10), 1009–1017.
2. Schluter, T., Baum, H., Plewan, A., & Neumeier, D. (2001). Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clinical Chemistry, 47(3), 459–463.
3. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237.
4. Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341(25), 1882–1890.
5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997). New England Journal of Medicine, 337(22), 1576–1583.
6. Hallas, C. N., Burke, J. L., White, D. G., & Connelly, D. T. (2010). A prospective 1-year study of changes in neuropsychological functioning after implantable cardioverter-defibrillator surgery. Circulation. Arrhythmia and Electrophysiology, 3(2), 170–177.
7. van den Broek, K. C., Nyklicek, I., & Denollet, J. (2009). Anxiety predicts poor perceived health in patients with an implantable defibrillator. Psychosomatics, 50(5), 483–492.
8. Sears, S. F., Jr., Todaro, J. F., Lewis, T. S., Sotile, W., & Conti, J. B. (1999). Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clinical Cardiology, 22(7), 481–489.
9. Bilge, A. K., Ozben, B., Demircan, S., Cinar, M., Yilmaz, E., & Adalet, K. (2006). Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing and Clinical Electrophysiology, 29(6), 619–626.
10. Burg, M. M., Lampert, R., Joska, T., Batsford, W., & Jain, D. (2004). Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosomatic Medicine, 66(6), 898–902.
11. Lampert, R., Joska, T., Burg, M. M., Batsford, W. P., McPherson, C. A., & Jain, D. (2002). Emotional and physical precipitants of ventricular arrhythmia. Circulation, 106(14), 1800–1805.
12. Hegel, M. T., Griegel, L. E., Black, C., Goulden, L., & Ozahowski, T. (1997). Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. International Journal of Psychiatry in Medicine, 27(1), 57–69.
13. Aronow, W. S. (2010). Use of implantable cardioverter-defibrillators. Future Cardiology, 6(6), 859–870.
14. Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck, K. H., Zipes, D. P., et al. (2000). Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. European Heart Journal, 21(24), 2071–2078.
15. Ingles, J., Sarina, T., Kasparian, N., & Semsarian, C. (2013). Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. International Journal of Cardiology. 168(4), 3779–3784.
16. Freedenberg, V., Thomas, S. A., & Friedmann, E. (2011). Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Failure Clinic, 7(1), 59–68.
17. Chevalier, P., Cottraux, J., Mollard, E., Sai, N., Brun, S., Burri, H., et al. (2006). Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. American Heart Journal, 151(1), 191.
18. Fitchet, A., Doherty, P. J., Bundy, C., Bell, W., Fitzpatrick, A. P., & Garratt, C. J. (2003). Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart, 89(2), 155–160.
19. Lewin, R. J., Coulton, S., Frizelle, D. J., Kaye, G., & Cox, H. (2009). A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart, 95(1), 63–69.
20. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.
21. Julian, L. J. (2011). Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Research (Hoboken), 63(Suppl 11), S467–S472.
22. Kertz, S., Bigda-Peyton, J., & Bjorgvinsson, T. (2012). Validity of the Generalized Anxiety Disorder-7 Scale in an Acute Psychiatric Sample. Clinical Psychology & Psychotherapy. 20(5), 456–464.
23. Kuhl, E. A., Dixit, N. K., Walker, R. L., Conti, J. B., & Sears, S. F. (2006). Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing and Clinical Electrophysiology, 29(6), 614–618.
24. Burns, J. L., Serber, E. R., Keim, S., & Sears, S. F. (2005). Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. Journal of Cardiovascular Electrophysiology, 16(4), 384–390.
25. Habibovic, M., Versteeg, H., Pelle, A. J., Theuns, D. A., Jordaens, L., & Pedersen, S. S. (2013). Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. Europace, 15(3), 355–361.
26. Magyar-Russell, G., Thombs, B. D., Cai, J. X., Baveja, T., Kuhl, E. A., Singh, P. P., et al. (2011). The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. Journal of Psychosomatic Research, 71(4), 223–231.
27. Godemann, F., Butter, C., Lampe, F., Linden, M., Schlegl, M., Schultheiss, H. P., et al. (2004). Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clinical Cardiology, 27(6), 321–326.
28. Jacq, F., Foulldrin, G., Savoure, A., Anselme, F., Baguelin-Pinaud, A., Cribier, A., et al. (2009). A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. General Hospital Psychiatry, 31(3), 266–273.
29. Van den Broek, K. C., Nyklicek, I., Van der Voort, P. H., Alings, M., & Denollet, J. (2008). Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing and Clinical Electrophysiology, 31(7), 850–857.
30. Chevalier, P., Verrier, P., Kirkorian, G., Touboul, P., & Cottraux, J. (1996). Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator: a psychometric study. Psychotherapy and Psychosomatics, 65(1), 49–56.
31. Dunbar, S. B., Langberg, J. J., Reilly, C. M., Viswanathan, B., McCarty, F., Culler, S. D., et al. (2009). Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing and Clinical Electrophysiology, 32(10), 1259–1271.
32. Redhead, A. P., Turkington, D., Rao, S., Tynan, M. M., & Bourke, J. P. (2010). Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. Journal of Psychosomatic Research, 69(6), 555–563.
33. Pedersen, S. S., Sears, S. F., Burg, M. M., & Van Den Broek, K. C. (2009). Does ICD indication affect quality of life and levels of distress? Pacing and Clinical Electrophysiology, 32(2), 153–156.
34. Sears, S. F., Sowell, L. D., Kuhl, E. A., Kovacs, A. H., Serber, E. R., Handberg, E., et al. (2007). The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing and Clinical Electrophysiology, 30(7), 858–864.